Bookshelf

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

The Guide to Clinical Preventive Services 2014: Recommendations of the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 May.

Cover of The Guide to <a href=Clinical Preventive Services 2014" width="80px" height="100px" />

The Guide to Clinical Preventive Services 2014: Recommendations of the U.S. Preventive Services Task Force.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 May.

Preventive Services Recommended by the USPSTF

Section 1 Preventive Services Recommended by the USPSTF

The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians discuss these preventive services with eligible patients and offer them as a priority. All these services have received an “A” or a “B” (recommended) grade from the Task Force. Refer to the endnotes for each recommendation for population-specific clinical considerations.

For definitions of all grades used by the USPSTF, see Appendix A (beginning on p. 97). The full listings of all USPSTF recommendations for adults begin on p. 5 and recommendations for children begin on p. 65.

RecommendationAdultsSpecial Populations
MenWomenPregnant WomenChildren/Adolescents
Abdominal Aortic Aneurysm, Screening 1
Alcohol Misuse Screening and Behavioral Counseling
Aspirin for the Prevention of Cardiovascular Disease 2
Bacteriuria, Screening 3
BRCA-Related Cancer in Women, Screening 4
Breast Cancer, Preventive Medications 5
Breast Cancer, Screening 6
Breastfeeding, Counseling 7
Cervical Cancer, Screening 8
Chlamydial Infection, Screening 9
Colorectal Cancer, Screening 10
Congenital Hypothyroidism, Screening 11
Depression in Adults, Screening 12
Diabetes Mellitus, Screening 13
Falls in Older Adults, Counseling, Preventive Medication, and Other Interventions 14
Folic Acid Supplementation to Prevent Neural Tube Defects, Preventive Medication 15
Gestational Diabetes Mellitus, Screening 16
Gonococcal Ophthalmia Neonatorum, Preventive Medication 17
Gonorrhea, Screening 18
Hearing Loss in Newborns, Screening 19
Hepatitis B Virus Infection in Pregnant Women, Screening 20
Hepatitis C Virus Infection in Adults, Screening 21
High Blood Pressure in Adults, Screening
HIV Infection, Screening 22
Intimate Partner Violence and Elderly Abuse, Screening 23
Iron Deficiency Anemia, Prevention 24
Iron Deficiency Anemia, Screening 25
Lipid Disorders in Adults, Screening 26
Lung Cancer, Screening 27
Major Depressive Disorder in Children and Adolescents, Screening 28
Obesity in Adults, Screening 29
Obesity in Children and Adolescents, Screening 30
Osteoporosis, Screening 31
Phenylketonuria (PKU), Screening 32
Sexually Transmitted Infections, Counseling 33
Sickle Cell Disease in Newborns, Screening 34
Skin Cancer, Counseling 35
Syphilis Infection (Pregnant Women), Screening
Tobacco Use in Adults, Counseling and Interventions 36
Tobacco Use in Children and Adolescents, Primary Care Interventions 37
Visual Impairment in Children Ages 1 to 5, Screening 38

One-time screening by ultrasonography in men aged 65 to 75 who have ever smoked.

When the potential harm of an increase in gastrointestinal hemorrhage is outweighed by a potential benefit of a reduction in myocardial infarctions (men aged 45–79 years) or in ischemic strokes (women aged 55–79 years).

Pregnant women at 12–16 weeks gestation or at first prenatal visit, if later.

Refer women whose family history is associated with an increased risk for deleterious mutations in BRCA1 or BRCA 2 genes for genetic counseling and evaluation for BRCA testing.

Engage in shared, informed decisionmaking and offer to prescribe risk-reducing medications, if appropriate, to women aged ≥35 years without prior breast cancer diagnosis who are at increased risk.

Biennial screening mammography for women aged 50 to 74 years. Note: The Department of Health and Human Services, in implementing the Affordable Care Act, follows the 2002 USPSTF recommendation for screening mammography, with or without clinical breast examination, every 1–2 years for women aged 40 and older.

Interventions during pregnancy and after birth to promote and support breastfeeding.

Screen with cytology every 3 years (women ages 21 to 65) or co-test (cytology/HPV testing) every 5 years (women ages 30–65).

Sexually active women 24 and younger and other asymptomatic women at increased risk for infection. Asymptomatic pregnant women 24 and younger and others at increased risk.

Adults aged 50–75 using fecal occult blood testing, sigmoidoscopy, or colonoscopy.

When staff-assisted depression care supports are in place to assure accurate diagnosis, effective treatment, and followup.

Asymptomatic adults with sustained blood pressure greater than 135/80 mg Hg.

Provide intervention (exercise or physical therapy and/or vitamin D supplementation) to community-dwelling adults ≥65 years at increased risk for falls.

All women planning or capable of pregnancy take a daily supplement containing 0.4 to 0.8 mg (400 to 800 μg) of folic acid.

Asymptomatic pregnant women after 24 weeks of gestation.

Sexually active women, including pregnant women 25 and younger, or at increased risk for infection.

Screen at first prenatal visit.

Persons at high risk for infection and adults born between 1945 and 1965.

All adolescents and adults ages 15 to 65 years and others who are at increased risk for HIV infection and all pregnant women.

Asymptomatic women of childbearing age; provide or refer women who screen positive to intervention services.

Routine iron supplementation for asymptomatic children aged 6 to 12 months who are at increased risk for iron deficiency anemia.

Routine screening in asymptomatic pregnant women.

Men aged 20–35 and women over age 20 who are at increased risk for coronary heart disease; all men aged 35 and older.

Asymptomatic adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit smoking within the past 15 years.

Adolescents (age 12 to 18) when systems are in place to ensure accurate diagnosis, psychotherapy, and followup.

Patients with a body mass index of 30 kg/m2 or higher should be offered or referred to intensive, multicomponent behavioral interventions.

Screen children aged 6 years and older; offer or refer for intensive counseling and behavioral interventions.

Women aged 65 years and older and women under age 65 whose 10-year fracture risk is equal to or greater than that of a 65-year-old white woman without additional risk factors.

All sexually active adolescents and adults at increased risk for STIs.

Children, adolescents, and young adults aged 10 to 24 years.

Ask all adults about tobacco use and provide tobacco cessation interventions for those who use tobacco; provide augmented, pregnancy-tailored counseling for those pregnant women who smoke.

Provide interventions to prevent initiation of tobacco use in school-aged children and adolescents.

Screen children ages 3 to 5 years.